Association Between Lifetime Classic Psychedelic Use and Hypertension in the Past Year

Population Survey Data Informing the Therapeutic Potential of Classic and Novel Phenethylamine, Tryptamine, and Lysergamide Psychedelics

(2020) James D. Sexton et al.   Frontiers in Psychiatry

The Current Status of Psychedelics in Psychiatry

(2020) David Nutt et al.   JAMA Psychiatry

Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects

(2020) Friederike Holze et al.   NEUROPSYCHOPHARMACOLOGY

Psychedelics as a novel approach to treating autoimmune conditions

(2020) Caitlin Thompson et al.   IMMUNOLOGY LETTERS

The global burden of hypertension exceeds 1.4 billion people

(2019) Brent M. Egan et al.   JOURNAL OF HYPERTENSION

Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry

(2019) Kornelia Kotseva et al.   European Journal of Preventive Cardiology

Cessation and reduction in alcohol consumption and misuse after psychedelic use

(2019) Albert Garcia-Romeu et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Chronic inflammation in the etiology of disease across the life span

(2019) David Furman et al.   NATURE MEDICINE

Is LSD toxic?

(2018) David E. Nichols et al.   FORENSIC SCIENCE INTERNATIONAL

2018 ESC/ESH Guidelines for the management of arterial hypertension

(2018) Bryan Williams et al.   EUROPEAN HEART JOURNAL

Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews

(2018) Rafael G. dos Santos et al.   Expert Review of Clinical Pharmacology

Hypertension—A Public Health Challenge of Global Proportions

(2018) Naomi D. L. Fisher et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Treatment of Hypertension

(2018) Arman Qamar et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The relationships of classic psychedelic use with criminal behavior in the United States adult population

(2017) Peter S Hendricks et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Effects of stress on the development and progression of cardiovascular disease

(2017) Mika Kivimäki et al.   Nature Reviews Cardiology

Psychiatry & the psychedelic drugs. Past, present & future

(2017) James J.H. Rucker et al.   NEUROPHARMACOLOGY

The 21st century psychedelic renaissance: heroic steps forward on the back of an elephant

(2017) Ben Sessa   PSYCHOPHARMACOLOGY

Psilocybin with psychological support for treatment-resistant depression: six-month follow-up

(2017) R. L. Carhart-Harris et al.   PSYCHOPHARMACOLOGY

Mental Health and Cardiovascular Disease

(2016) Ashish Chaddha et al.   AMERICAN JOURNAL OF MEDICINE

The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization

(2016) Ede Frecska et al.   Frontiers in Pharmacology

Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population

(2015) Peter S Hendricks et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities

(2015) Attila Szabo   Frontiers in Immunology

Associations between mental disorders and subsequent onset of hypertension

(2013) Dan J. Stein et al.   GENERAL HOSPITAL PSYCHIATRY

Drug harms in the UK: a multicriteria decision analysis

(2010) David J Nutt et al.   LANCET